Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Journal of Infection Année : 2021

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.

Dates et versions

hal-04456661 , version 1 (14-02-2024)

Identifiants

Citer

Aurelie Guigon, Emmanuel Faure, Chloé Lemaire, Marie-Charlotte Chopin, Claire Tinez, et al.. Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.. Journal of Infection, 2021, Journal of Infection, 84, pp.P248-288. ⟨10.1016/j.jinf.2021.08.033⟩. ⟨hal-04456661⟩
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More